A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

References

• AaproMMolassiotisAOliverIAnticipatory nausea and vomitingSupport Care Cancer2005131172115599779
   PubMed Web of Science ®Google Scholar
• AbrahmJLA physician’s guide to pain and symptom management in cancer patients20052Baltimore, MDThe Johns Hopkins University Press
   Google Scholar
• AhmedzaiSCarlyleDLCalderITAnti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapyBr J Cancer198348657636315040
   PubMed Web of Science ®Google Scholar
• AndrewsPLRNaylorRJJossRANeuropharmacology of emesis and its relevance to anti-emetic therapy. Consensus and controversiesSupport Care Cancer199861972039629870
   PubMed Web of Science ®Google Scholar
• Aprepitant (Emend®). 2005. [package insert]. Merck and Co., Inc
   Google Scholar
• Ben AmarMCannabinoids in medicine: a review of their therapeutic potentialJ Ethnopharmacol200610512516540272
   PubMed Web of Science ®Google Scholar
• BerlachDMShirYWareMAExperience with the synthetic cannabinoid in chronic noncancer painPain Med20067252916533193
   PubMed Web of Science ®Google Scholar
• BonicaJJEvolution and current status of pain programsJ Pain Symptom Manage19905368741702822
   PubMedGoogle Scholar
• ChanHSCorreiaJAMacLeodSMNabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trialPediatrics198779946523035479
   PubMed Web of Science ®Google Scholar
• CrawfordSMBuckmanRNabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind studyMed Oncol Tumor Pharmacother1986339423010011
   PubMedGoogle Scholar
• CroxfordJLTherapeutic potential of cannabinoids in CNS diseaseCNS Drugs20031717920212617697
   PubMed Web of Science ®Google Scholar
• CunninghamDBradleyCJForrestGJA randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesEur J Cancer Clin Oncol19882468592838294
   PubMedGoogle Scholar
• DautRLCleelandCSThe prevalence and severity of pain in cancerCancer1982501913187116316
   PubMed Web of Science ®Google Scholar
• DianaMAMartAEndocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE)Br J Pharmacol200414291915100161
   PubMed Web of Science ®Google Scholar
• EinhornLHNagyCFurnasBWilliamsSDNabilone: An effective antiemetic in patients receiving cancer chemotherapyJ Clin Pharmacol198121suppl6469
   Web of Science ®Google Scholar
• FabreLFMcLendonDThe efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxietyJ Clin Pharmacol198121377S6117575
   PubMed Web of Science ®Google Scholar
• FreundTFKatonaIPiomelliDRole of endogenous cannabinoids in synaptic signalingPhysiol Rev20038310176612843414
   PubMed Web of Science ®Google Scholar
• FrideEBregmanTKirkhamTCEndocannabinoids and food intake: Newborn suckling and appetite regulation in adulthoodExp Biol Med200523022534
   PubMed Web of Science ®Google Scholar
• GrallaRJde WitRHerrstedtJAntiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trialsCancer2005104864815973669
   PubMed Web of Science ®Google Scholar
• GrunbergSMAdvances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimensBlood Rev19893216212692744
   PubMed Web of Science ®Google Scholar
• HermanTSEinhornLHJonesSESuperiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapyN Engl J Med197930012957375088
   PubMed Web of Science ®Google Scholar
• HermanTSJonesSEDeanJNabilone: a potent antiemetic cannabinol with minimal euphoriaBiomedicine1977273314606307
   PubMedGoogle Scholar
• HickokJTRoscoeJAMorrowGRNausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemeticsCancer2003972880612767103
   PubMed Web of Science ®Google Scholar
• HornbyPJCentral neurocircuitry associated with emesisAm J Med2001111suppl 8A10612
   PubMed Web of Science ®Google Scholar
• HowlettACBarthFBonnerTIInternational union of pharmacology. XXVII. Classification of cannabinoid receptorsPharmacol Rev20025416120212037135
   PubMed Web of Science ®Google Scholar
• JennsKImportance of nauseaCancer Nurs199417488937820827
   PubMed Web of Science ®Google Scholar
• KalantHMedicinal use of cannabis: history and current statusPain Res Manage200168091
   PubMedGoogle Scholar
• KrisMGHeskethPJSomerfieldMRAmerican Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006J Clin Oncol20062429324716717289
   PubMed Web of Science ®Google Scholar
• LeeJDibbleSLPickettMChemotherapy-induced nausea/vomiting and functional status in women treated for breast cancerCancer Nurs2005282495516046885
   PubMed Web of Science ®Google Scholar
• LembergerLRoweHClinical pharmacology of nabilone, a cannabinol derivativeClin Pharm Ther19751872026
   PubMed Web of Science ®Google Scholar
• LimebeerCLHallGParkerLAExposure to a lithium-paired context elicits gapin in rats: A model of anticipatory nauseaPhysiol Behav20068839840316737724
   PubMed Web of Science ®Google Scholar
• LynchMEPreclinical science regarding cannabinoids as analgesics: an overviewPain Res Manage200510suppl A7A14A
   PubMedGoogle Scholar
• MackAJoyJMarijuana as Medicine2001Washington, DCNational Academy Press
   Google Scholar
• MalikIAKhanWAQazilbashMClinical efficacy of lorazepam in prophylaxis of anticipatory acute and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trialAm J Clin Oncol19951817057900711
   PubMed Web of Science ®Google Scholar
• MartinBRWileyJLMechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and painJ Support Oncol2004230514 discussion 314–1615357514
   PubMedGoogle Scholar
• MeiriEJhangianiHVredenburghJJEfficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomitingCurr Med Res Opin2007235334317355735
   PubMed Web of Science ®Google Scholar
• MorranCSmithDCAndersonDAIncidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomized trial of antiemeticsBMJ1979113234445053
   PubMed Web of Science ®Google Scholar
• MorrowGRRoscoeJAKirshnerJJAnticipatory nausea and vomiting in the era of 5-HT3 antiemeticsSupport Care Cancer1998624479629877
   PubMed Web of Science ®Google Scholar
• NahasGHarveyDJSutinKA molecular basis of the therapeutic and psychoactive properties of cannabis (D9-tetrahydrocannabinol)Prog Neuro-Psychopharmacol Biol Psychiatry20022672130
   PubMed Web of Science ®Google Scholar
• National Cancer Institute2006 [online] Accessed 9 September 2006. URL: http://www.meds.com/pdq/supportive_pro.html
   Google Scholar
• National Comprehensive Cancer NetworkClinical Practice Guidelines in Oncology. Antiemesis. v2.2006 [online]2006 Accessed 9 September 2006. URL: http://www.nccn.org
   Google Scholar
• NavariRPathogenesis-based treatment of chemotherapy-induced nausea and vomiting – two new agentsJ Support Oncol200318910315352652
   PubMedGoogle Scholar
• NiederleNSchutteJSchmidtCGCrossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapyKlin Wochenschr19866436253009962
   PubMedGoogle Scholar
• NiiranenAMattsonKA cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapyAm J Clin Oncol19858336403002167
   PubMed Web of Science ®Google Scholar
• NiiranenAMattsonKAntiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapyAm J Clin Oncol19871032593039831
   PubMed Web of Science ®Google Scholar
• NotcuttWPriceMMillerRInitial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ’N of 1’ studiesAnaesthesia2004594405215096238
   PubMed Web of Science ®Google Scholar
• ParkerLAKempSWTetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: an animal model of anticipatory nausea and vomiting (ANV)Neuroreport2001127495111277577
   PubMed Web of Science ®Google Scholar
• ParkerLAKwiatkowskaMMechoulamRDelta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomitingPhysiol Behav200687667116197970
   PubMed Web of Science ®Google Scholar
• PiomelliDThe molecular logic of endocannabinoid signalingNat Rev Neurosci200348738414595399
   PubMed Web of Science ®Google Scholar
• Poli-BigelliSRodrigues-PereiraJCaridesADon behalf of the Aprepitant Protocol 054 Study GroupAddition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomitingCancer2003973090812784346
   PubMed Web of Science ®Google Scholar
• PomeroyMFennellyJJTowersMProspective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesisCancer Chemother Pharmacol198617285883017596
   PubMed Web of Science ®Google Scholar
• PriestmanTJPriestmanSGAn initial evaluation of nabilone in the control of radiotherapy-induced nausea and vomitingClin Radiol19843526566329586
   PubMed Web of Science ®Google Scholar
• PriestmanSGPriestmanTJCanneyPAA double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nauseaClin Radiol19873854342822337
   PubMed Web of Science ®Google Scholar
• RazaviDDelvauxNFarvacquesCPrevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolamJ Clin Oncol1993111384908315437
   PubMed Web of Science ®Google Scholar
• RoscoeJAMorrowGRHickokJTNausea and vomiting remain a significant clinical problemJ Pain Symptom Mange20002011321
   PubMed Web of Science ®Google Scholar
• SchlickerEKathmannMModulation of transmitter release via presynaptic cannabinoid receptorsTrends Pharmacol Sci2001225657211698100
   PubMed Web of Science ®Google Scholar
• SchwartzbergLChemotherapy-induced nausea and vomiting: state of the art in 2006J Support Oncol2006suppl 13816499138
   PubMedGoogle Scholar
• ShakespeareDTBoggildMYoungCAnti-spasticity agents for multiple sclerosisCochrane Database Syst Rev2003CD00133214583932
   PubMed Web of Science ®Google Scholar
• StockhorstUKlosterhalfenSKlosterhalfenWAnticipatory nausea in cancer patients receiving chemotherapy: classical conditioning etiology and therapeutical implicationsIntegr Physiol Behav Sci199328177818318445
   PubMed Web of Science ®Google Scholar
• StrasserFLuftnerDPossingerKComparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-GroupJ Clin Oncol200624339440016849753
   PubMed Web of Science ®Google Scholar
• SunCCBodurkaDCWeaverCBRankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancerSupport Care Cancer2004132192715538640
   PubMed Web of Science ®Google Scholar
• TramérMRCarrollDCampbellFACannabinoids for control of chemotherapy-induced nausea and vomiting: quantitative systematic reviewBMJ20013231811440920
   PubMed Web of Science ®Google Scholar
• VanscoyGJFortnerBSmithRPreventing chemotherapy-induced nausea and vomiting: the economic implications of choosing antiemeticsCommun Oncol20052127132
   Google Scholar
• VinciguerraVMooreTBrennanEInhalation marijuana as an antiemetic for cancer chemotherapyN Y State J Med19888852573231372
   PubMedGoogle Scholar
• WaknineYFDA approvals: Lumigan, Cesamet, OmnitropeMedscape Medical News2006 July 14, 2006. Accessed 9 September 2006. URL: http://www.medscape.com/viewarticle/540937
   Google Scholar
• WardAHolmesBNabilone. A preliminary review of its pharmacological properties and therapeutic useDrugs198530127442863127
   PubMed Web of Science ®Google Scholar
• WiserWBergerAPractical management of chemotherapy-induced nausea and vomitingOncology2005196374515945344
   PubMed Web of Science ®Google Scholar
• WisselJHaydnMullerJLow dose treatment with the synthetic cannabinoid nabilone significantly reduces spasticity-related pain. A double-blind placebo-controlled cross-over trialJ Neurol200620221820
   Google Scholar